| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 6, 2022 | Jun 8, 2022 | Quince Therapeutics, Inc. | EVP, Preclinical Development | Sell | 36.3 | -10,920 | -6.87% | ✓ | $31.2K |
| Dec 14, 2020 | Dec 15, 2020 | Quince Therapeutics, Inc. | President | Sell | 5.0 | -40,000 | -30.00% | ✓ | $1.2M |